Understanding the role and use of essential medicines lists
Related news and resources
76th WHO Regional Committee for Africa: Special update on the ongoing Ebola virus disease outbreak caused by Bundibugyo Virus
On 26 August, IFPMA delivered a statement on the special update on the ongoing Ebola virus disease outbreak caused by Bundibugyo Virus at the 76th session off the WHO Regional Committee for Africa in Addis Ababa. Marking the 100th day after the Bundibugyo outbreak was declared, the global pharmaceutical industry underscores its commitment and track...
Read more76th WHO Regional Committee for Africa: Regional strategy on regulation of medical products in the African region, 2026-2035
On 26 August 2026, IFPMA delivered a statement on the regional strategy on regulation of medical products in the African region, 2026-2035, during the 76th WHO Regional Committee for Africa in Addis Ababa, Ethiopia. IFPMA welcomes the proposed Strategy on Regulation of Medical Products, and commends WHO AFRO, Member States, and regional institutions for their...
Read moreAMATA Statement at WHO Regional Committee for Africa: Regional strategy on regulation of medical products in the African Region, 2026-2035
The members of the African Medicines Agency Treaty Alliance (AMATA) welcome and strongly support the Regional Strategy on Regulation of Medical Products in the African Region, 2026–2035. Access to safe, effective, quality-assured medical products depends on a strong regulatory system. However, a truly harmonized and effective regulatory system cannot be achieved without continental coordination and...
Read more